news
Radicle Science and Holobiome Launch 6,000-Person Prebiotic Trial for Anxiety
Radicle Science and Holobiome opened enrollment for a decentralized clinical trial testing 19 different prebiotic formulations against a placebo in over 6,000 people. The two-year study aims to pinpoint which specific fibers improve self-reported anxiety and map how distinct bacterial strains influence mood. Initial data is scheduled for release in late 2027.
Radicle Science and Holobiome opened enrollment for a decentralized clinical trial testing 19 different prebiotic formulations against a placebo in over 6,000 people. The two-year study aims to pinpoint which specific fibers improve self-reported anxiety and map how distinct bacterial strains influence mood. Initial data is scheduled for release in late 2027.
The architecture take
Most supplement studies test thirty college students for six weeks and declare a victory for mental clarity, so a decentralized trial running 6,000 people across 20 distinct arms is genuinely unusual. The science behind the gut-brain axis is solid enough in rodent models, but human data has been messy because dumping generic inulin into an inflamed microbiome often just causes bloating rather than calm. What Holobiome is after is bacterial precision: finding specific fermentable fibers that selectively feed microbes producing GABA and short-chain fatty acids, which signal the brain through the vagus nerve and dial down sympathetic nervous system arousal. I spent two years buying every chic prebiotic powder on the shelf before admitting that half of them simply wrecked my digestion and did nothing for my 3 p.m. tension. If this trial successfully matches particular prebiotic inputs to verified anxiety drops across distinct gut profiles, it will force the entire supplement aisle to abandon one-size-fits-all fiber blends.